Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is SUNITNIB MALATE, with a corresponding US DMF Number 32927.
Remarkably, this DMF maintains an Active status since its submission on March 15, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 06, 2019, and payment made on January 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II